<DOC>
	<DOCNO>NCT00313391</DOCNO>
	<brief_summary>The purpose study determine Risperdal Consta affect healthcare utilization cost chronically ill schizophrenic patient multiple admission psychiatric hospital compare previous utilization cost standard oral treatment atypical antipsychotic . We hypothesize high Risperdal Consta acquisition cost offset reduction total medical utilization cost , hospitalization , ER visit , unscheduled outpatient visit incarceration due worsen psychotic symptom .</brief_summary>
	<brief_title>Risperdal Consta Health Care Utilization Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Primary diagnosis schizophrenia schizoaffective disorder 4 admission psychiatric hospital past year , OR minimum 2 hospital admission least 2 incarceration previous year Medicaid recipient Patients require concomitant nonantipsychotic psychotropic medication ( mood stabilizing , antidepressant , anxiolytic ) Past current psychiatric disorder , schizophrenia schizoaffective disorder Drug alcohol dependence Serious , unstable medical illness acute medical condition Pregnant lactating female Prior Risperdal Consta treatment NonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>